MultiPark: Multidisciplinary research focused on Parkinson´s disease
1741 – 1750 of 3880
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Determining clinically meaningful decline in preclinical Alzheimer disease
(
- Contribution to journal › Article
-
Mark
European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)
(
- Contribution to journal › Article
-
Mark
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
(
- Contribution to journal › Article
-
Mark
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
-
Mark
The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells
(
- Contribution to journal › Article
-
Mark
Environmental Challenges in the Home for Ageing Societies : a Comparison of Sweden and Japan
(
- Contribution to journal › Article
-
Mark
Parkinson disease and growth factors — is GDNF good enough?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Alzheimer’s disease not linked to type 2 diabetes or high blood pressure – new study
(
- Contribution to specialist publication or newspaper › Specialist publication article